Internal Medicine, Cardiovascular Disease · Memphis, TN
NPI
1922190396
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
8060 Wolf River Blvd
Memphis, TN, 38138
Phone (901) 271-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$474K
21,609 services
Medicare patients, 2024
907
Average age 77
Drug cost, 2024
$5.4M
15,874 prescriptions
Company payments, 2025
$13K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank A McGrew was code 36415 (venipuncture blood collection), 2,207 times for 822 patients. In total Frank A McGrew billed 21,609 services in 61 codes, and Medicare paid $474K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 2,207 | 822 | $8.58 | $19K |
| 93000 Electrocardiogram | Office | 2,036 | 811 | $9.51 | $19K |
| 80053 Clinical Chemistry | Office | 1,910 | 771 | $10.33 | $20K |
| 85025 Blood Count | Office | 1,875 | 772 | $7.60 | $14K |
| 84443 Clinical Chemistry | Office | 1,629 | 760 | $16.46 | $27K |
| 80061 Clinical Chemistry | Office | 1,626 | 771 | $13.04 | $21K |
| 82550 Clinical Chemistry | Office | 1,619 | 766 | $6.34 | $10K |
| 82977 Clinical Chemistry | Office | 1,573 | 763 | $7.01 | $11K |
| 83735 Clinical Chemistry | Office | 1,556 | 731 | $6.53 | $10K |
| 99214 Office E&M - Established | Office | 1,357 | 663 | $85.88 | $117K |
| 83880 Clinical Chemistry | Office | 1,069 | 479 | $38.29 | $41K |
| 99215 Office E&M - Established | Office | 899 | 536 | $116.13 | $104K |
| 93298 External Electrocardiographic Monitoring | Office | 437 | 54 | $66.99 | $29K |
| 85610 Clinical Chemistry | Office | 335 | 46 | $4.20 | $1,407 |
| 93793 Care Management/Coordination | Office | 270 | 24 | $6.87 | $1,855 |
By year: 2022 $540K for 27,705 services; 2023 $603K for 35,669 services; 2024 $474K for 21,609 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,207 | 822 | $8.58 | $19K |
| 80053 Clinical Chemistry | 1,910 | 771 | $10.33 | $20K |
| 85025 Blood Count | 1,875 | 772 | $7.60 | $14K |
| 84443 Clinical Chemistry | 1,629 | 760 | $16.46 | $27K |
| 80061 Clinical Chemistry | 1,626 | 771 | $13.04 | $21K |
| 82550 Clinical Chemistry | 1,619 | 766 | $6.34 | $10K |
| 82977 Clinical Chemistry | 1,573 | 763 | $7.01 | $11K |
| 83735 Clinical Chemistry | 1,556 | 731 | $6.53 | $10K |
| 83880 Clinical Chemistry | 1,069 | 479 | $38.29 | $41K |
| 85610 Clinical Chemistry | 335 | 46 | $4.20 | $1,407 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank A McGrew prescribed most often to Medicare patients was Ezetimibe, with 1,369 prescriptions and refills. In total Frank A McGrew wrote 15,874 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,369 | 3,401 | 392 | $37K |
| Rosuvastatin Calcium Generic | 1,248 | 3,216 | 371 | $17K |
| Atorvastatin Calcium Generic | 816 | 2,185 | 232 | $9,033 |
| Metoprolol Succinate Generic | 679 | 1,690 | 186 | $10K |
| Amlodipine Besylate Generic | 658 | 1,612 | 198 | $3,243 |
| Losartan Potassium Generic | 637 | 1,684 | 189 | $7,009 |
| Eliquis Apixaban | 586 | 949 | 127 | $538K |
| Clopidogrel Clopidogrel Bisulfate | 512 | 1,243 | 142 | $5,251 |
| Amiodarone Hcl Generic | 492 | 1,006 | 138 | $8,148 |
| Carvedilol Generic | 479 | 1,203 | 138 | $4,476 |
| Doxazosin Mesylate Generic | 450 | 984 | 113 | $10K |
| Entresto Sacubitril/Valsartan | 417 | 640 | 92 | $401K |
| Repatha Sureclick Evolocumab | 382 | 601 | 81 | $338K |
| Spironolactone Generic | 368 | 842 | 102 | $2,619 |
| Furosemide Generic | 354 | 758 | 105 | $1,279 |
Brand drugs: - claims; generic drugs: 12,748 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank A McGrew $13K ($13K in general payments such as food, travel and fees) from 29 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $7,468.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $7,468 |
| Medtronic, Inc. MDT | 17 | $2,541 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 23 | $524 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $357 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $302 |
| Merck Sharp & Dohme LLC MRK | 13 | $248 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $208 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $194 |
| Alnylam Pharmaceuticals Inc. ALNY | 8 | $185 |
| Novo Nordisk Inc NVO | 7 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.